Covaxin may get WHO approval by month-end, says NITI Aayog

15-09-2021 Wed 20:35 IST | IANS | National

New Delhi, Sep 15 : India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients to travel abroad without mandatory quarantine, NITI Aayog's Member, Health, V.K. Paul said on Wednesday.

Data sharing and data evaluation are going on and a positive decision may come soon, he said.

"The data sharing and data evaluation have been going on through multiple reviews and we are close to a decision point.

"We must give time to WHO to make their decisions based on science. However, we hope that these decisions can be taken quickly because people who are receiving Covaxin have certain imperatives of travel. Most of us, who chose the concurrency, is important in terms of licensure. We are hoping for an early decision," Dr Paul said.

"We believe that a positive decision could be coming in, before the end of the month," he added.

In August, Indian Health Minister Mansukh Mandaviya also met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the WHO approval of Covaxin.

The vaccine's developer Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

The WHO has so far approved Covid-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna, and Sinopharm.


More News
From 2004 tsunami to Covid-19: A timeline of Quad elevation
17 minutes ago
Modi arrives in US for Quad summit, bilateral talks with leaders
21 minutes ago
Covishield not a problem, discussing certification with app builders: British envoy
7 hours ago
Hyderabad BJP MLA complains of receiving threatening calls
8 hours ago
Internet connectivity in over 4,000 Andhra villages by year-end: CM
8 hours ago
Adani completes acquisition of Gangavaram Port
8 hours ago
Pradhan writes to Jagan over Andhra-Odisha border dispute
9 hours ago
IPIPL 2021: Delhi continue their good form, register commanding win over Hyderabad
9 hours ago
Ease of Doing Business: India launches single window clearance portal
9 hours ago
Hidden camera phone found in women's washroom at Hyderabad restaurant
9 hours ago
ZEEL merger with Sony hinges on shareholder nod amid row with Invesco, OFI Global
9 hours ago
Need to continue labour, product markets reforms for growth: RBI Guv
9 hours ago
Neeraj gets puppy named 'Tokyo' as a gift from Bindra
10 hours ago
IPL 2021: Delhi bowlers combine forces to keep Hyderabad at 134/9
10 hours ago
SCBA President writes to CJI on various issues of the Bar
10 hours ago
Xi Jinping shakes investor confidence by targeting China's private sector
10 hours ago
Rs 50K for each Covid death from state disaster relief funds, SC told
10 hours ago
Popularity ratings trigger CM changes: IANS CVoter tracker
10 hours ago
Youth who planted filmy-style (Geetha Govindam) kiss on girl in bus held in K'taka
11 hours ago
Centenarian who 'flew' aircraft says 'calmness' is key to staying energetic
11 hours ago
Dalit leader killing: Woman beheaded in revenge, head placed at his home
11 hours ago
Liver abscesses most common in India -- and Covid-19 has pushed up the numbers
11 hours ago
If I don't win, someone else will become CM: Mamata
11 hours ago
Global cues, volatility pull equity indices down, banking stocks slip
11 hours ago
'Wash women's clothes': Bihar court's bail condition for rape accused
11 hours ago
India at forefront of global response to Covid pandemic: President
11 hours ago
SC collegium recommends re-transfer of Justice Bagchi to Calcutta HC
11 hours ago
Air India CMD Bansal appointed Civil Aviation Secretary
12 hours ago
IPL 2021: Hyderabad elect to bat first against Delhi
12 hours ago
NASA splits its human spaceflight unit into two
13 hours ago